Liver tumors and steroid hormones in rats and mice.

No abstract is available for this paper.

• Publication year

  1979

• Venue

  Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-642-67265-1_16PMID 288329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathology of tumors in laboratory animals: Vol. II: Tumors of the Mouse. IARC Scientific Publication, WHO, Paris, 1980

  1980cited by this paper
• Non-mutagenicity of some sex hormones in the Ames salmonella/microsome mutagenicity test.

  1979cited by this paper
• 636 – ADAPTIVE LIVER GROWTH - A POSSIBLE CAUSE OF TUMOR PROMOTION BY STEROID HORMONES IN RAT LIVER

  1978cited by this paper
• Structural modifications in contraceptive steroids altering their metabolism and toxicity

  1977cited by this paper
• [Problems of dose finding: sexual hormones (author's transl)].

  1977cited by this paper
• Irreversible protein binding of norethisterone (norethindrone) epoxide.

  1976cited by this paper
• Carcinogenicity studies in animals relevant to the use of anabolic agents in animal production.

  1976cited by this paper
• Carcinogenicity studies in animals relevant to the use of anabolic agents in animal production.

  1976cited by this paper
• The estrogen‐cancer hypothesis

  1976cited by this paper
• Hyperplastic areas, hyperplastic nodules, and hyperbasophilic areas as putative precursor lesions.

  1976cited by this paper
• Metabolic activation of norethisterone (norethindrone) to an irreversibly protein-bound derivative by rat liver microsomes.

  1975cited by this paper
• Report of a workshop on classification of specific hepatocellular lesions in rats.

  1975cited by this paper
• Irreversible binding of ethynyl-estradiol metabolites to protein and nucleic acids as catalyzed by rat liver microsomes and mushroom tyrosinase.

  1974cited by this paper
• Irreversile binding of ethynyl-estradiol metabolites to protein and nucleic acids as catalyzed by rat liver microsomes and mushroom tyrosinas

  1974cited by this paper
• Irreversible protein binding of metabolites of ethynylestradiol in vivo and in vitro.

  1973cited by this paper
• Some aspects of the interaction between natural and synthetic female sex hormones and the liver.

  1970cited by this paper
• Long-term toxicologic and tumorigenesis studies on an oral contraceptive agent in albino rats.

  1970cited by this paper
• Use of the life-table technique to estimate effects of certain steroids on probability of tumor formation in a long-term study in rats.

  1968cited by this paper
• Cellular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenylacetamide or ethionine and some aspects of their morphology and glycogen metabolism.

  1967cited by this paper
• Comparative chronic toxicity of three oral estrogens in rats.

  1967cited by this paper
• Development of preneoplastic and neoplastic lesions of the liver in male rats given 0.025 percent N-2-fluorenyldiacetamide.

  1965cited by this paper
• Liver tumours produced in rats by feeding safrole.

  1963cited by this paper
• Prolonged toxicity studies of a norethindrone-estrogen combination in rats [abstract]

  1962cited by this paper
• Hormonal aspects of experimental tumorigenesis.

  1953cited by this paper
• The incidence of spontaneous hepatomas in C3H, C3H (low milk factor), and CBA mice and the effect of estrogen and androgen on the occurrence of these tumors in C3H mice.

  1952cited by this paper
• Studies on the occurrence of spontaneous hepatomas in mice of strains C3H and CBA.

  1950cited by this paper
• Mammary tumors in male mice implanted with estrogen-cholesterol pellets.

  1946cited by this paper
• Spontaneous Primary Hepatomas in Mice of Strain C3H III. The Effect of Estrogens and Testosterone Propionate on Their Incidence

  1943cited by this paper

• Respective roles of Pik3ca mutations and cyproterone acetate impregnation in mouse meningioma tumorigenesis

  2023cites this paper
• Chemicals with Carcinogenic Activity Primarily in Rodent Liver

  2018cites this paper
• Differential impacts of mineralocorticoid receptor antagonist potassium canrenoate on liver and renal changes in high fat diet-mediated early hepatocarcinogenesis model rats.

  2018cites this paper
• Transgenic rat models for mutagenesis and carcinogenesis

  2017cites this paper
• Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver

  2017cites this paper
• From the Cover: Genomic Effects of Androstenedione and Sex-Specific Liver Cancer Susceptibility in Mice

  2017cites this paper
• In Vivo Alkaline Comet Assay and Enzyme-modified Alkaline Comet Assay for Measuring DNA Strand Breaks and Oxidative DNA Damage in Rat Liver.

  2016cites this paper
• Efectos del arsénico sobre la adenohipófisis. Mecanismos de acción

  2014cites this paper
• Sex-specific dose-response analysis of genotoxicity in cyproterone acetate-treated F344 rats.

  2014cites this paper
• Cytotoxicity and Genotoxicity of Depo-Provera , © Medroxyprogesterone Acetate ( DMPA ) in Female Rats

  2013cites this paper
• Liver and Pancreas

  2012cites this paper
• Liver Hypertrophy

  2012cites this paper
• Removal of the toxic effects of chlormadinon acetate on the development of Drosophila melanogaster via the use of nordihydroguaiaretic acid

  2011cites this paper
• Chemicals with Carcinogenic Activity in Rodent Liver

  2010cites this paper
• Dimethyl nitrosamine-induced proliferative and neoplastic lesions in the mouse liver characterized by histopathology and flow cytometric DNA measurements.

  2009cites this paper
• Medroxyprogesterone Acetate (DMPA) in Female Rats

  2009cites this paper
• Antigenotoxic effect of nordihydroguaiaretic acid against chlormadinone acetate-induced genotoxicity in mice bone-marrow cells

  2007cites this paper
• 9 – Liver and Pancreas

  2007cites this paper
• Follow-up testing of rodent carcinogens not positive in the standard genotoxicity testing battery: IWGT workgroup report.

  2007cites this paper
• Influence of a-Naphthoflavone on the Metabolism and Binding of Ethinylestradiol in Male Syrian Hamster Liver Microsomes: Possible Role in Hepatocarcinogenesis1

  2006cites this paper
• Activation and Inactivation of Carcinogens and Mutagens by Human Sulfotransferases

  2005cites this paper
• Long term phenobarbital administration does not promote the multiplication of hepatocytes replicating after single cyproterone acetate administration.

  2005cites this paper
• Liver structure and function during long-term treatment with cyproterone acetate

  2005cites this paper
• In vivo induction of sister chromatid exchanges (SCEs) and chromosomal aberrations (CAs) by lynestrenol.

  2005cites this paper
• No-effect level in the mutagenic activity of the drug cyproterone acetate in rat liver. Part I. Single dose treatment.

  2004cites this paper
• Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens.

  2004cites this paper
• No-effect level in the mutagenic activity of the drug cyproterone acetate in rat liver. Part II. Multiple dose treatment.

  2004cites this paper
• Are some progestins genotoxic liver carcinogens?

  2002cites this paper
• In vivo cell lineage analysis in cyproterone acetate–treated rat liver using genetic labeling of hepatocytes

  2002cites this paper
• Dose dependent induction of DNA adducts, gene mutations, and cell proliferation by the antiandrogenic drug cyproterone acetate in rat liver.

  2001cites this paper
• IARC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS

  2000cites this paper
• Induction of proliferative lesions of the uterus, testes, and liver in swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action.

  2000cites this paper
• Digestive System 2

  2000cites this paper
• Sex-specific induction of apoptosis by cyproterone acetate in primary rat hepatocytes.

  1999cites this paper
• DNA adduct formation of selected sex steroids in human liver slices in vitro.

  1998cites this paper
• The DNA damaging drug cyproterone acetate causes gene mutations and induces glutathione-S-transferase P in the liver of female Big Blue transgenic F344 rats.

  1998cites this paper
• Induction of micronuclei and of enzyme-altered foci in the liver of female rats exposed to progesterone and three synthetic progestins.

  1998cites this paper
• Sense and Non-Sense in Toxicity Assessment of Medicinal Products

  1997cites this paper
• Cyproterone Acetate

  1996cites this paper
• The liver as origin and target of reactive intermediates exemplified by the progesterone derivative, cyproterone acetate.

  1996cites this paper
• Commentary on the publication: Tucker MJ, Jones DV. Effects of cyproterone acetate in C57B1/10J mice.

  1996cites this paper
• Steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation.

  1996cites this paper
• Effects of cyproterone acetate in C57Bl/10J mice

  1996cites this paper
• Time-related induction of DNA repair synthesis in rat hepatocytes following in vivo treatment with cyproterone acetate.

  1996cites this paper
• SHORT COMMUNICATION: Time-Related introduction of DNA repair synthesis in rat hepatocytes following in vivo treatment with cyproterone acetate

  1996cites this paper
• Studies on the formation of hepatic DNA adducts by the antiandrogenic and gestagenic drug, cyproterone acetate: 1. adduct levels in various species including man and 2. persistence and accumulation in the rat.

  1996cites this paper
• Induction of micronuclei and initiation of enzyme-altered foci in the liver of female rats treated with cyproterone acetate, chlormadinone acetate, or megestrol acetate.

  1996cites this paper
• Divide and rule

  1996cites this paper
• Letter to the Editor

  1996cites this paper
• Formation of DNA-adducts by selected sex steroids in rat liver

  1996cites this paper
• Gender bender

  1995cites this paper
• Biomarkers as tools in human health risk assessment.

  1995cites this paper
• Depot‐medroxyprogesterone acetate (DMPA) and risk of liver cancer

  1991cites this paper
• Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.

  1990cites this paper
• Ovulationshemmer: Die Bedeutung der Östrogendosis

  1990cites this paper
• Sex hormones and neoplasia: liver tumors in rodents.

  1987cites this paper
• Äthinyloestradiol und Hepatocarcinogenese. Eine experimentelle Beobachtung

  1987cites this paper
• [Ethinyl estradiol and hepatocarcinogenesis. An experimental study].

  1987cites this paper
• Estrogens and Progestins as Tumor Inducers

  1987cites this paper
• Histochemical and immunohistochemical detection of putative preneoplastic liver foci in women after long-term use of oral contraceptives

  1986cites this paper
• Increased UDP-Glucuronyltransferase in putative preneoplastic foci of human liver after long-term use of oral contraceptives

  1985cites this paper
• Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients.

  1983cites this paper
• Oral contraceptive steroids as promoters or complete carcinogens for liver in female Sprague-Dawley rats.

  1983cites this paper
• Proliferative liver lesions and sex steroids in rats

  1982cites this paper
• Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds, and nafenopin.

  1981cites this paper
• Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. I. Induction of drug-metabolizing enzymes.

  1980cites this paper
• Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. II. Induction of growth.

  1980cites this paper
• Adaptive liver growth induced by xenobiotic compounds: its nature and mechanism.

  1979cites this paper